Zai Lab Announces Presentations at March Conferences

SHANGHAI, China, March 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited ZLAB, a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the senior management team will present and participate in three upcoming events in March in greater China. Details of the presentations are as follows:

• Morgan Stanley's Ninth Annual Hong Kong Investor Summit
  Presentation: Tuesday, March 26, 2019 at 11:30am CT
  Presenter: Billy Cho, CFO
  Location: International Commerce Centre, Hong Kong             

• 10^th Annual China Healthcare Investment Conference
  Presentation: Wednesday, March 27, 2019 at 9:30am CT
  Keynote: Dr. Samantha Du, Founder and CEO
  Location: Ritz Carlton, Shanghai            

• Credit Suisse's 22^nd Asian Investment Conference
  Presentation: Wednesday, March 27, 2019 at 9:30am CT
  Presenter: Billy Cho, CFO
  Location: Conrad Hotel, Hong Kong

Individuals may access more information on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investors" section. 

About Zai Lab

Zai Lab ZLAB is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide.

Contact:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Nancie Steinberg / Robert Flamm
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 318 / 364, nsteinberg@burnsmc.com / rflamm@burnsmc.com

Investors: Jill Steier
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 367, jsteier@burnsmc.com